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ABSTRACT: In an eﬀort to characterize the roles of each metal ion in metallo-
β-lactamase NDM-1, heterodimetallic analogues (CoCo-, ZnCo-, and CoCd-) of
the enzyme were generated and characterized. UV−vis, 1H NMR, EPR, and EXAFS
spectroscopies were used to conﬁrm the ﬁdelity of the metal substitutions, including
the presence of a homogeneous, heterodimetallic cluster, with a single-atom bridge.
This marks the ﬁrst preparation of a metallo-β-lactamase selectively substituted with
a paramagnetic metal ion, Co(II), either in the Zn1 (CoCd-NDM-1) or in the Zn2
site (ZnCo-NDM-1), as well as both (CoCo-NDM-1). We then used these metal-
substituted forms of the enzyme to probe the reaction mechanism, using steady-
state and stopped-ﬂow kinetics, stopped-ﬂow ﬂuorescence, and rapid-freeze-quench
EPR. Both metal sites show signiﬁcant eﬀects on the kinetic constants, and both
paramagnetic variants (CoCd- and ZnCo-NDM-1) showed signiﬁcant structural
changes on reaction with substrate. These changes are discussed in terms of a
minimal kinetic mechanism that incorporates all of the data.
■ INTRODUCTION
β-Lactam-containing antibiotics that target bacterial cell wall
synthesis, such as penicillins, cephalosporins, and carbapenems,
remain the cheapest and some of the most eﬀective anti-
microbial agents available,1 representing more than 50% of the
antibiotics prescribed worldwide. The selective pressure applied
by their wide and extensive application has resulted in
resistance,2 conferred by the production of β-lactamases.
More than 1,000 β-lactamases have been isolated, and these
enzymes have been categorized into four classes based on
amino acid sequence.1,3 Classes A, C, and D, also known as the
serine-β-lactamases (SβLs), use an active site serine to perform
nucleophilic attack on the β-lactam carbonyl, forming a covalent
enzyme−substrate adduct, and these enzymes generally display
very narrow substrate proﬁles, although examples of SβLs with
broad activity have recently been reported.4,5 In contrast, Class B
β-lactamases, also known as the metallo-β-lactamases (MβLs),
require either 1 or 2 equiv of Zn(II) for full catalytic activity,
and these enzymes hydrolyze all clinical β-lactam-containing
compounds. The MβLs have been further divided into subclasses
B1−B3, based on sequence homology.6
Although SβLs are more clinically prevalent than MβLs, they
remain sensitive to an array of mechanism-based inhibitors,
such as clavulanic acid, sulbactam, and tazobactam. The MβLs
are generally insensitive to SβL inhibitors, and no clinical in-
hibitors exist for these enzymes. A number of clinically
important bacterial strains have been reported to produce
chromosomally encoded MβLs, such as Bacillus cereus (BcII),7
Bacteroides f ragilis (CcrA),8 Elizabethkingia meningoseptica
(BlaB),9 and Stenotrophomonas maltophilia (L1).10 Several
plasmid-encoded MβLs, such as IMP11 and VIM12 variants,
have been shown to horizontally transfer to other pathogenic
bacteria. NDM-1 was initially discovered in Klebsiella pneumonia.
Like blaIMP‑1 and blaVIM‑1, blaNDM‑1 has been shown to be
horizontally transferable.13 Clinical strains of Enterobacteriaceae
and A. baumannii now harbor the blaNDM‑1 gene.
14−16 IMP,
VIM, and NDM are all class B1 MβLs, by far the most
abundant and clinically relevant subclass of the MβLs.17−19
The native Zn(II)-containing MβLs are accessible only by
X-ray crystallography and X-ray absorption spectroscopy (XAS).
Substitution of the active site Zn(II) with Co(II) is a common
practice, as it makes the enzymes amenable to NMR, EPR, and
UV−vis spectroscopies, allowing for more detailed structural
and mechanistic studies. However, as all known examples of
B1 MβLs bind 2 equiv of divalent metal tightly, spectroscopic
signatures from fully substituted enzymes are diﬃcult to assign
to speciﬁc metal sites (Zn1 or Zn2, Figure 1; for clarity, we will
refer to all metal-substituted variants in numerical order, that is,
ZnCo refers to Zn(II) in the Zn1 site and Co(II) in the Zn2 site).
While heterodimetallic forms are desirable, well-characterized
examples are relatively few. Vila and co-workers ﬁrst reported
spectroscopic studies on a mixed-metal (ZnCo) form of BcII.20
More recently, we reported spectroscopic studies on the ZnCo
form of the B3 MβL L1.21 However, structural and catalytic
features speciﬁc to the Zn1 site cannot be established without a
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complementary form of the enzyme that incorporates a para-
magnetic metal ion in the Zn1 site and a diamagnetic metal ion in
the Zn2 site.
We report here the preparation, characterization, and
mechanistic investigation of several heterodimetallic forms of
the MβL NDM-1, in an eﬀort to establish the functional roles
of each metal ion. The reaction of these mixed-metal forms
with chromacef was followed using rapid-freeze-quench (RFQ)
EPR, allowing a detailed assessment of the coordination
environment of each metal binding site, independently, during
the formation and decay of a key ring-opened reaction intermediate
that is commonly formed by most MβLs with chormacef or
nitroceﬁn as substrate (a similar intermediate has been reported in
the reaction of BcII with penicillin22 and imipenem23). The
minimal reaction mechanism developed here is discussed in light of
the available data on NDM-1, both reported previously19,24 and
herein.
■ EXPERIMENTAL PROCEDURES
Materials. Escherichia coli strains DH5a and BL21(DE3) were
purchased from Novagen (Madison, WI). Restriction enzymes, NdeI
and XhoI, were purchased from New England Biolabs. Luria−Bertani
(LB) medium was purchased from Invitrogen (Carlsbad, CA).
Isopropyl-β-D-thiogalactoside (IPTG) was purchased from Anatrace
(Maumee, OH). Chromacef was purchased from Sopharmia, Inc. All
buﬀer solutions and growth media were made with Barnstead
NANOpure water. Kinetic and spectroscopic studies were conducted
in 50 mM HEPES (pH 7.0) containing 200 mM NaCl and 1 mM
TCEP [tris(2-carboxyethyl)phosphine] (referred to simply as “buﬀer”
from here). All dialyses were performed against buﬀer containing
10 mM EDTA (“chelation buﬀer”), 12 h per buﬀer volume.
Preparation of apo-, CoCo-, ZnCo-, and CoCd-NDM-1. NDM-1
was expressed and puriﬁed as described previously.19 Protein
concentrations were determined using the extinction coeﬃcient at
280 nm, ε280 = 28,500 M
−1 cm−1. To prepare apo-NDM-1, the puriﬁed
enzyme (ca. 300 μM) was dialyzed at 4 °C against 3 × 1 L of chelation
buﬀer. EDTA was removed by dialysis against 6 × 1 L of buﬀer. CoCo-
NDM-1 was prepared by titrating 300 μM apo-NDM-1 with Co(II) in
buﬀer. The mixed-metal hybrids were prepared by incubating 300 μM
apoenzyme, with 1 equiv of the diamagnetic metal from a 10 mM
stock solution in buﬀer, followed by addition of Co(II), also from a
10 mM stock. For example, ZnCo-NDM-1 was prepared by incubating
the apoenzyme with 1 equiv of Zn(II) on ice for 30 min, followed by
titration with Co(II). The CoCd enzyme was prepared in a similar
fashion, by incubation of the apoenzyme with 1 equiv of Cd(II),
followed by the addition of 1 equiv of Co(II).
Steady-State Kinetics. Steady-state kinetic studies were per-
formed using 50 nM enzyme at 9 °C, unless otherwise noted, on a
Hewlett-Packard 5480A diode array spectrophotometer. The hydrol-
ysis of chromacef by ZnZn-, CoCo-, ZnCo-, and CoCd-NDM-1 was
monitored by detecting the formation of product at 442 nm, and
absorbance data were converted into concentrations using Δε442 =
18,600 M−1 cm−1. Kinetic studies were carried out in buﬀer, with
substrate concentrations that varied from 1 to 100 μM. The initial rate
of product formation vs substrate concentration was ﬁt to the
Michaelis−Menten equation to determine the steady-kinetic constants,
Km and kcat.
NMR Spectroscopy. 1H NMR spectra were collected on 2 mM
samples of metal-substituted NDM-1 in buﬀer containing ∼10% D2O.
Exchangeable protons were identiﬁed by comparison with samples in
∼90% D2O. 1H NMR spectra were recorded at 290 K on a Bruker
ASX200 spectrometer operating at 200.13 MHz. Data were collected
using a frequency switching technique that places a long, low-power
(saturating) pulse on the water signal, before moving the transmitter
to an arbitrary region of interest.25 This approach allows accentuation
of severely hyperﬁne-shifted resonances and often more uniform
excitation. Spectra for NDM-1 collected in this manner were the
average of ∼200,000 transients consisting of 8k points over a 75 kHz
spectral window (tAQ = 54 ms, total data collection took approximately
16 h per spectrum). The presaturation pulse was typically 100−150 ms
(∼1 W), centered at the water frequency, while the acquisition pulse
was 3 μs at full power, typically centered between +50 and +200 ppm.
Prior to Fourier transformation, all FIDs were apodized using an
exponential function that introduced an additional line width of 30 Hz
(0.15 ppm).
EXAFS Spectroscopy. Samples for EXAFS (approximately 1 mM
in protein) were prepared with 20% (v/v) glycerol as a glassing agent.
EXAFS samples were loaded in Lucite cuvettes with 6 μm
polypropylene windows and frozen rapidly in liquid nitrogen. X-ray
absorption spectra were measured at the National Synchrotron Light
Source (NSLS), beamline X3B, with a Si(111) double-crystal
monochromator; harmonic rejection was accomplished using a Ni
focusing mirror. Fluorescence excitation spectra for all samples were
measured with a 31-element solid-state Ge detector array. Samples
were held at approximately 15 K in a Displex cryostat. EXAFS data
collection and reduction were performed according to published
procedures.26 Data were measured in duplicate, six scans at the zinc
K-edge, eight scans at the cobalt K-edge, each on two samples from
independent puriﬁcations; ﬁts to the two data sets were equivalent. As
both data sets gave similar results, the data were averaged using
EXAFSPAK (EXAFSPAK is available free of charge from http://www-
ssrl.slac.stanford.edu/∼george/exafspak/exafs.htm); the experimental
spectra presented here are the averaged data sets (12−16 scans per
sample). The data were converted from energy to k-space using E0 =
9680 eV (Zn) or 7730 eV (Co).
Fourier-ﬁltered EXAFS data were ﬁt using the nonlinear least-
squares engine of IFEFFIT, which is distributed with SixPack (SixPack
is available free of charge from http://home.comcast.net/∼sam_
webb/sixpack.html; IFEFFIT is open source software available from
http://cars9.uchicago.edu/ifeﬃt). Theoretical amplitude and phase
functions were calculated with FEFF v. 8.00.27 Zinc-nitrogen single-
scattering and zinc-imidazole multiple-scattering was calibrated to the
experimental EXAFS of zinc tetrakis-1-methylimidazole Zn(II)
perchlorate, [Zn(MeIm)4][ClO4]2. Zinc-sulfur scattering was cali-
brated to the experimental EXAFS of tetrabutylammonium zinc
tetramesitylthiolate, [Bu4N]2[Zn(Smes)4]. Optimum scale factors (Sc)
and ΔE0 were derived from ﬁts to the model data (Sc = 0.78 (Zn−N)
or 0.91 (Zn−S); ΔE0= −21 eV) and were held ﬁxed at these values for
ﬁts to metalloprotein data. The models used for the calibration of
cobalt−nitrogen (and cobalt-imidazole) and cobalt−sulfur scattering
were, respectively, hexakis-imidazole cobalt(II) perchlorate, [Co-
(Im)6][ClO4]2 and tetrabutylammonium cobalt(II) tetramesitylthio-
late, [Bu4N]2[Co(Smes)4], respectively. The resulting Sc and ΔE0
(Sc = 0.79 (Co−N) or 0.85 (Co−S); ΔE0 = −21 eV) were held ﬁxed
at these calibrated values in subsequent ﬁts to metalloprotein data.
First shell ﬁts were then obtained for all reasonable coordination
numbers, including mixed nitrogen/oxygen/sulfur ligation, while
allowing the absorber-scattered distance, Ras, and the Debye−Waller
factor, σas
2, to vary. Detailed summaries of the ﬁtting results are
presented in Supporting Information. Multiple scattering contributions
from histidine ligands were ﬁtted according to published procedures.26
Figure 1. Active site structure of NDM-1 based on the current
spectroscopic studies, with the ligand arrangement based on the X-ray
structure of NDM-1 (Strynadka, et al.).50
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Metal-metal (zinc-cobalt and cobalt-cobalt) scattering were modeled
with reference to the experimental EXAFS of Zn2 (salpn)2 and Co2
(salpn)2; cobalt-cadmium scattering was ﬁtted empirically, assuming a
scale factor of Sc = 1.0.
Stopped-Flow Kinetics. Rapid-scanning visible spectra of
chromacef, hydrolyzed by NDM-1, were collected on an Applied Photo-
physics SX18MV spectrophotometer equipped with a photodiode array
detector and a 2 mm path length optical cell. The temperature was kept
constant at 9 °C (unless otherwise noted) using a circulating water bath.
Absorbance data were converted to concentration as described
previously.19 Stopped-ﬂow ﬂuorescence studies of chromacef hydrolysis
were conducted at 9 °C on the same Applied Photophysics
spectrometer, using an excitation wavelength of 295 nm and a
320 nm high-pass ﬁlter on the photomultiplier. The data obtained in
stopped-ﬂow studies were ﬁt with either single or double exponentials
using Pro-Data software. Single traces representing substrate, product, or
intermediate were simulated with Kinteksim, using the mechanism
shown in Scheme 1.
EPR Spectroscopy. Low temperature EPR spectra were collected
with a Bruker Elexsys E600 EPR spectrometer equipped with an
Oxford Instruments ESR900 helium ﬂow cryostat. Spectra were
recorded at 9.63 GHz (B0⊥B1) or 9.37 GHz (B0∥B1) using an
ER4116DM dual-mode cavity, with 10 G (1 mT) magnetic ﬁeld
modulation at 100 kHz. Microwave powers and temperatures employed
are given in the legends to ﬁgures, and other recording parameters were
chosen such that resolution was limited by the ﬁeld modulation
amplitude. Spin Hamiltonian parameters were estimated from computer
simulations carried out using XSophe (Bruker Biospin), assuming Ĥ =
βgBS + SDS + ASI, where S = 3/2, D ≫ βgBS, and I(59Co) = 7/2, and
where D > 0 implies MS = ±
1/2 and D < 0 implies MS = ±
3/2.
28
Rapid-Freeze-Quench EPR. Variants of NDM-1 (0.5 mM) were
reacted with 1.5 mM chromacef, each in buﬀer at 0 °C. The reaction
mixture was rapidly frozen after 10 ms using a previously described
system,29,30 and the quenched samples were analyzed by EPR
spectroscopy, as described above. Enzyme−product complex samples
were prepared by thawing the quenched reaction samples for 2 min
and refreezing.
■ RESULTS
Generation of apo-, CoCo-, ZnCo-, and CoCd-NDM-1.
Previous eﬀorts to prepare metal-substituted forms of NDM-1
involved the initial removal of Zn(II) with EDTA at pH > 7.0;
mass spectrometry revealed that the active site cysteine was
oxidized under these conditions.24 We also attempted to
prepare apo-NDM-1 by dialyzing the enzyme vs EDTA, across
a range of pH (6.0−7.5). Metal analyses revealed that the
apoenzyme contained < 0.1 equiv of Zn(II), < 0.05 equiv of Fe,
and no other common metal ions, regardless of the pH at which
it was dialyzed. Direct addition of Co(II) to the apoenzyme
resulted in immediate formation of a pink color, which rapidly
changed to orange, indicative of Co(II) oxidation.31 We also
attempted a biological incorporation method, developed for
preparation of heterodimetallic forms of L1.21 NDM-1 was
overexpressed in minimal medium, and the cell culture was
spiked with Co(II) at the time of induction. The resulting
enzyme, puriﬁed using previously published procedures,19
contained only 0.6−0.7 equiv of Co and 0.3 equiv of Fe.
Since these more common methods to generate Co(II)-
substituted MβLs were unsuccessful with NDM-1, we modiﬁed
the direct addition method by adding 1 mM TCEP (a reducing
agent) to the apoenzyme, prior to adding Co(II). The resulting
Co(II)-substituted NDM-1 samples were purple, and this color
was retained for months. We generated several other metal-
substituted enzymes in this way. Steady-state kinetic studies of
all variants, using chromacef as substrate, are summarized in
Table 1. All three metal-substituted forms of NDM-1 (ZnCo-,
CoCo-, and CoCd-) exhibited steady-state kcat and Km values
within a factor of 3 of those found for ZnZn-NDM-1 (kcat =
4.2 s−1, Km = 5.1 μM).
19
Optical Spectroscopy of Metal-Substituted NDM-1.
Previously reported optical spectra for Co(II)-substituted
NDM-1 were obtained from samples generated by addition
of Co(II) to ZnZn-NDM-1 containing 1 mM EDTA.19,24 With
the new method to generate metal-substituted forms of NDM-1
presented here, we obtained quantiﬁable optical spectra of
ZnCo-, CoCo-, and CoCd-NDM-1 by titration. Addition of
Co(II) to apo-NDM-1 suggests that cobalt distributes between
the Zn1 and Zn2 sites at substoichiometric concentrations
(Figure 2A, top), as it does in the B1MβLs BcII,32,33 Bla2,34
and IMP-135 and as has been shown previously for NDM-1.24
The ligand ﬁeld bands between 500 and 650 nm are apparent
with as little as 0.25 equiv of added Co(II). At 0.5 equiv of
added Co(II), an additional band at 330 nm is observed, and
subsequent additions only served to increase the intensity of
both features, monotonically. The 330 nm absorption is
characteristic of a Cys→Co(II) ligand-to-metal charge transfer,
indicative of metal binding at the Zn2 site, while the structure of
the ligand ﬁeld bands is reminiscent of that exhibited by high-
spin Co(II) in the pseudotetrahedral environment of the Zn1
site.36 Further addition of Co(II) to this sample resulted in a
monotonic increase in absorbance in both regions, maximizing
at 2.0 equiv of added Co(II), consistent with binding distributed
between the Zn1 and Zn2 sites, even at very low concentrations.
22
The ﬁnal spectra (ε330 = 1060, ε550 = 505, ε615 = 285 M
−1 cm−1
for two Co(II)/protein) are indistinguishable from those
reported for many other di-Co(II) B1 MβLs.18,22,24,32,35,37−40
The optical spectrum of ZnCo-NDM-1 (Figure 2A, center),
prepared by incubation of the apoenzyme with 1 equiv of
Zn(II) followed by titration with Co(II), shows a spectrum
similar in shape to that obtained from CoCo-NDM-1. Added
Co(II) leads directly to the appearance of both the LMCT
band at 330 nm and a broad, asymmetric set of ligand ﬁeld
bands (ε550 = 220 and ε615 = 115 M
−1 cm−1). However, in this
case, maximum absorbance of the LMCT (ε = 900 M−1 cm−1)
is achieved with 1 equiv of added Co(II), providing strong
evidence that it is bound primarily at the consensus Zn2 site,
forming ZnCo-NDM-1.35 In contrast, when the apoenzyme is
incubated with 1 equiv of Cd(II) followed by titration with
Co(II), the LMCT at 330 nm is nearly absent. The optical
spectrum of CoCd-NDM-1 (Figure 2A, bottom) shows only a
nearly symmetric pattern of four principal ligand ﬁeld bands,
Scheme 1
Table 1. Steady-State Parameters for Hydrolysis of
Chromacef by ZnZn-, ZnCo-, CoCo-, and CoCd- Analogues
of NDM-1
species
kcat
(s−1)
Km
(μM)
kcat/Km
(s−1/μM)
kcat(calc)
(s−1)a
Km(calc)
(μM)a
ZnZn 4.2 5.1 ± 0.9 0.8 4.8 0.1
ZnCo 2.0 1.9 ± 0.4 1.0 4.7 0.1
CoCo 3.7 5.6 ± 1.2 0.7 9.4 0.2
CoCd 5.5 5.6 ± 0.7 1.0 14 0.9
aTheoretical kcat and Km calculated using eq 1.
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reminiscent of Co(II)-substituted carbonic anhydrase
(CoCA).41 They maximize at 1 equiv of added Co(II) with
ε550 = 280 and ε615 = 220 M
−1 cm−1. Thus, the optical spectra
are consistent with Co(II) binding at the Zn1 site in CoCd-
NDM-1 and the Zn2 site in ZnCo-NDM-1.
Closer inspection of the ligand-ﬁeld regions for ZnCo-NDM-
1 and CoCd-NDM-1 (Figure 2B, top) further supports the
description of these samples as homogeneous heterobimetallic
enzymes. While the CoCd-NDM-1 spectrum is nearly identical
to that of resting CoCA,41 consistent with the pseudotetrahe-
dral geometry anticipated for Co(II) in the Zn1 site, the ZnCo-
NDM-1 spectrum shows a similar pattern of absorption maxima
at 510, 550, 615, and 640 nm, along with a shoulder to low
energy at 680 nm. However, the intensities are much higher in
the higher energy pair, an eﬀect that has been shown to be
directly attributable to the thiolate in the coordination sphere of
Co(II) in the Zn2 site.
42 The coordination sphere of the Zn2
ion most closely resembles that of the active site Zn(II) in
farnesyltransferase (FTase),43 and the ZnCo-NDM-1 spectrum
is generally similar to that of Co(II)-FTase,44 though the four
principal features in Figure 2B appear as two unresolved pairs at
∼560 and 635 nm in Co(II)-FTase, with slightly smaller
extinction coeﬃcients. Simple addition of the ZnCo- and
CoCd-NDM-1 spectra closely matches the ligand ﬁeld region
of the CoCo- enzyme, particularly for the higher energy pair
(Figure 2B, bottom). This minimal dependence of the spectrum
on the identity of the other metal is consistent with weak coupling
between the metals, supported by the EPR (below).
NMR Spectroscopy of Metal-Substituted NDM-1. To
better deﬁne the binding sites occupied by Co(II) in CoCo-,
ZnCo-, and CoCd-NDM-1, 1H NMR spectra were recorded
(Figure 3). The NMR spectrum of CoCo-NDM-1 (Figure 3,
top) shows a number of hyperﬁne-shifted signals spanning 170
to −80 ppm. Spectra of similar complexity have been reported
for other B1 MβLs, most notably CcrA and BcII,20,45 with the
majority of the resonances upﬁeld of +40 ppm ascribed to
secondary interactions with nearby residues in the active site,
and those downﬁeld of +40 ppm to ligand protons. Exchange of
this sample into D2O buﬀer revealed a number of solvent-
exchangeable protons (marked by asterisks in Figure 3, both
spectra are shown in Supplementary Figure S1). Four of them,
clustered between −10 and −25 ppm, presumably arise from
outer sphere interactions with backbone amides. The other four
(119, 87, 77, and 61 ppm) are readily assigned to the NH
protons of Co(II)-coordinated histidines. With analogy to other
cobalt-bound cysteinates, we can assign the broad resonance at
170 ppm to one, or both, of the β-CH2 protons of a Co(II)-
coordinated cysteine.20,25,45−49 The D2O spectrum (Supple-
mentary Figure S1) reveals a broad resonance at 84 ppm,
underlying the two most downﬁeld His resonances. While the
chemical shift is consistent with expectation for the α-
methylene protons of a terminally Co(II)-coordinated carbox-
ylate,46,50−52 the similarity of its line width to the resonance at
170 ppm suggests that the resonance at 84 ppm is the geminal
partner of the Cys β-proton at 170 ppm. Previous studies of
blue-copper proteins have shown that diﬀerence in the Cys β-
CH2 proton chemical shifts is directly proportional to the Co−
S−C−H dihedral angle.47,48,53−56 The 86 ppm chemical shift
diﬀerence, therefore, indicates a signiﬁcant deviation in the
Co−S−C−H dihedral angles from the symmetric ideal of 60°.
Of the remaining nonexchangeable resonances (most likely
among the three at 50, 53, and 61 ppm), two are likely from the
α-CH2 geminal pair of Asp124.
51
The NMR spectrum of ZnCo-NDM-1 (Figure 3, center)
retains the majority of the weakly and upﬁeld-shifted
resonances seen for CoCo-NDM-1. However, it retains only
one of the four solvent-exchangeable resonances assigned to
His NH protons in CoCo-NDM-1. This resonance most likely
derives from His250, which is the only histidine in the Zn2 site
of NDM-1. Its chemical shift increases from 119 to 127 ppm,
reﬂecting loss of the competing inﬂuence of a second, likely
antiferromagnetically coupled Co(II) ion (below). A similar
observation can be made for all of the ligand protons to the
Figure 2. (A) Optical spectra of CoCo-, CoCd-, and ZnCo- analogues of NDM-1. (Top) Titration of apo-NDM-1 with 0.5−2.0 equiv of Co(II).
(Center) Apo-NDM-1, incubated with 1 equiv of Zn(II) and then titrated with 0.5 and 1.0 equiv of Co(II). (Bottom) Apo-NDM-1, incubated with 1
equiv of Cd(II) and then titrated with 0.5 and 1.0 equiv of Co(II). The data are plotted on the same scale, oﬀset vertically for clarity. (B) Expanded
view of the ligand ﬁeld region. (Top) Overlay of CoCd- (black) and ZnCo-NDM-1 (gray) spectra. (Bottom) Comparison of the CoCo-NDM-1
ligand ﬁeld region (black) to the sum of the CoCd- and ZnCo-NDM-1 data (gray).
Figure 3. 200 MHz 1H NMR spectra of Co(II)-substituted analogues
of NDM-1 in 90% H2O. Solvent-exchangeable protons are marked
with asterisks. Transmitter imperfections are marked with an X.
Journal of the American Chemical Society Article
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Zn2-site: all of their chemical shifts increase when a diamagnetic
metal occupies the Zn1 site. The most downﬁeld shifted Cys
β-methylene protons could not be observed, except when the
transmitter was placed within ±20 ppm. Under these
conditions, two distinct resonances are observed, at 189 and
201 ppm. Assignment of these two resonances as the Cys β-
CH2 geminal pair would require the β-proton chemical shift
diﬀerence to be reduced from 86 to 12 ppm, on swapping
Co(II) for Zn(II) in the Zn1-site. This can happen only if the
Zn2-site Co(II) ion’s g tensor reorients signif icantly between the
two forms of the enzyme (assuming the cysteine is in the same
conformation in both proteins). Alternatively, the observation
of two distinct resonances in this region could represent two
distinct subpopulations that diﬀer slightly in dihedral angle. We
favor this interpretation, as the remainder of the spectrum, in
particular the nonexchangeable resonances at 57 and 86 ppm,
closely resembles that of CoCo-NDM-1. The broad resonance
at 86 ppm also shows evidence of two closely overlapped
signals and is similar in width and position to the 84 ppm
resonance apparent in the CoCo-NDM-1 spectrum in D2O
(Supplementary Figure S1). The 57 ppm resonance is
substantially more intense in the ZnCo-NDM-1 spectrum
relative to the analogous resonances in the CoCo-NDM-1
spectrum. We therefore suggest that this resonance most likely
arises from the α-CH2 pair of Asp124, showing a slight
alteration of the Co−O−C−H dihedral angle when the metal
in the Zn1-site is changed.
In contrast, the NMR spectrum of CoCd-NDM-1 (Figure 3,
bottom) is remarkably simple, with only six prominent
hyperﬁne shifted signals, including a poorly resolved pair at
48−50 ppm. Exchange of this sample into D2O buﬀer revealed
that three of these are solvent-exchangeable (at 50, 56, and
71 ppm, Supplementary Figure S1). The pattern, together with
the optical spectra discussed above, suggests these should be
assigned to the NH protons of His120, His122, and His189 in
the Zn1 site. Overall, the chemical shift dispersion displayed by
the ligand protons when Co(II) occupies the Zn1 site (CoCd-
NDM-1) is smaller than when Co(II) occupies the Zn2 site
(ZnCo-NDM-1). These observations are consistent with a 5-
coordinate Co(II) in ZnCo-NDM-1, expected to display
relatively large dipolar shifts, and a 4-coordinate Co(II) in
CoCd-NDM-1, which should induce only minimal dipolar
shifts.57−59 The simplicity of the CoCd spectrum further
indicates that the majority of the second sphere interactions
that give rise to hyperﬁne shifted proton signals in the CoCo
spectrum derive from the Zn2 site, and their absence further
attests to the homogeneity of the Co(II) population in the
CoCd enzyme.
EXAFS of Resting CoCo-, ZnCo-, and CoCd-NDM-1.
EXAFS spectroscopy was used to further verify the ﬁdelity of
the metal substitutions, including the presence of an intact
binuclear center, and to probe the metal−metal separations.
Fourier-transformed Co K-edge EXAFS data for CoCo-NDM-1
are shown at the top of Figure 4. Detailed ﬁtting results for all
three metal-substituted variants are presented in Supplementary
Figures S2−S4 and Tables S1−S3. Pertinent details are
summarized in Table 2. The best ﬁt to the CoCo-NDM-1
data indicated a ﬁrst shell of 4 N/O and 0.5 S donors per Co.
Inclusion of the sulfur in the ﬁt is critical, based on a 47%
improvement in the ﬁrst-shell ﬁt residual (see Supplementary
Figure S2 and Table S1, compare ﬁts S1-1 and S1-2). Multiple
scattering analyses indicate an average of 2 imidazoles per Co,
while the addition of a Co-Co vector at 3.51 Å resulted in a
66% reduction in the ﬁt residual (compare ﬁts S1-3 and S1-4).
This is 0.13 Å longer than the 3.38 Å Zn−Zn separation in
ZnZn-NDM-1,19 reﬂecting the larger covalent radius of Co(II).
The EXAFS clearly show that addition of 2 equiv of Co(II) to
apo-NDM-1 results in formation of an intact, singly bridged
binuclear center.
XAS of ZnCo-NDM-1 aﬀords the unique opportunity to
examine both metal sites independently. The best ﬁts to the
Fourier-transformed Zn K-edge and Co K-edge EXAFS data for
ZnCo-NDM-1 are also shown in Figure 4; detailed ﬁtting
results are shown in Supplementary Figures S3 and S4 and
Tables S2 and S3, respectively. The Zn K-edge EXAFS data
were best ﬁt with a ﬁrst shell of 4 N/O donors, including 3
imidazole ligands per Zn(II). Addition of a Co−Zn scattering
pathway at 3.45 Å improved the ﬁt residual by 30% (compare
ﬁts S2-2 and S2-3). Inspection of the corresponding ﬁts
(Supplementary Figure S3) shows that the metal−metal vector
dramatically improves the ﬁt at R + α > 2.8 Å, but a shorter
distance interaction near R + α ≈ 2.1 Å remains unmatched.
We initially attempted to ﬁt this part of the spectrum with a
Zn−S interaction, on the assumption that perhaps it
represented a small amount of scrambling between the two
metal sites, and would thus give us a semiquantitative measure
of the homogeneity of the enzyme. However, all attempts to ﬁt
this interaction as a Zn−S were visually unsatisfactory, leading
to only marginal improvements in the ﬁt residuals and mostly
unreasonable distances (compare ﬁts S2-3 and S2-5). The
largest Zn−S contribution that gave reasonable parameters
would suggest no more than 20% of the total enzyme held
Zn(II) in the Zn2 site. In contrast, inclusion of a Zn−CCO2
−
interaction at 2.51 Å nicely reproduced this feature and reduced
the ﬁt residual by a remarkable 73% (compare ﬁts S2-3 and S2-4).
The requirement that this feature be a part of the ﬁnal ﬁt suggests
a more intimate connection to Asp124 than expected for metal
bound at the Zn1 site, but the presence of an additional
carboxylate bridge would be expected to lead to substantially
shorter metal−metal separations than observed.26,60
The corresponding Co K-edge EXAFS were best ﬁt with a
ﬁrst shell of 4 N/O and 1 S donor (inclusion of the cobalt−sulfur
path improves the ﬁt by 46%; compare ﬁts S3-1 and S3-2).
Multiple scattering ﬁts indicate only one imidazole ligand, while
inclusion of an additional Co−Zn scattering pathway at 3.47 Å
improved the ﬁt to the data by 26% (compare ﬁts S3-3 and
S3-4). In this case, inclusion of a Co−CCO2− scattering pathway
at 2.47 Å further lowered the ﬁt residual by another 44%. The
Figure 4. Fourier-transformed EXAFS spectra (solid lines) for metal-
substituted forms of NDM-1 and best ﬁts (open symbols). From top
to bottom: CoCo-NDM-1 (Co K-edge), ZnCo-NDM-1 (Zn K-edge),
ZnCo-NDM-1 (Co K-edge), CoCd-NDM-1 (Co K-edge).
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two M−M ﬁts are in excellent agreement, and the set show
a smooth progression, from 3.38 (Zn−Zn) to 3.45 (CoZn) to
3.51 Å (CoCo). Taken together, the EXAFS of ZnCo-NDM-1
indicate a highly homogeneous enzyme, with Zn(II) binding at
the Zn1 site and Co(II) binding at the Zn2 site in a
heterodimetallic center.
Fourier-transformed Co K-edge EXAFS data for CoCd-
NDM-1 are shown at the bottom of Figure 4. Detailed ﬁtting
results are shown in Supplementary Figure S5 and Table S4.
The best ﬁt was obtained with a ﬁrst shell of 4 N/O donors.
The addition of a sulfur scatterer in the ﬁrst shell resulted in a
poorer ﬁt (not shown). Multiple scattering ﬁts indicate 3
imidazole ligands per Co ion. Inclusion of a Co−Cd vector at
3.56 Å improved the ﬁt by about 26%. A second shallow minimum
is observed with a 3.79 Å Co−Cd vector, and a ﬁt that includes both
distances, reﬁning the respective coordination numbers, suggests no
more than an 80/20 distribution between the two distances. Overall,
these data are again consistent with the description above, with Co
occupying the Zn1 site and Cd occupying the Zn2 site in CoCd-
NDM-1, in an intact binuclear center.
EPR of Resting CoCo-, ZnCo-, and CoCd-NDM-1. The
EPR spectrum of CoCo-NDM-1 under nonsaturating con-
ditions (Figure 5A) exhibited a broad, axial signal with a peak at
g′ = 5.2 (1300 G) that could be simulated assuming an axial g
tensor with MS = ±
1/2, g⊥ = 2.26, g∥ = 2.45, and E/D = 0.1. All
of the B0⊥B1 EPR spectra contain a sharp signal at g′ ≈ 4.3
(1800 G) that is due to a few percent of bound Fe(III). The
broad lines and the proximity of the Co(II) ions in the Zn1 and
Zn2 sites suggests spin−spin coupling between the Co(II) ions,
and integer-spin signals were directly observable at lower
temperature and higher power (Figure 5B) and with B0∥B1
(Figure 6A). A resonance at g′ ≈ 8 (800 G) suggested a
transition in the S′ = 2 manifold of an S = 0, 1, 2, 3 spin ladder,
and a distinct signal appearing out of zero ﬁeld is indicative of
interdoublet transitions. These signals require the value of J to
be very small, on the order of a few cm−1 or less, consistent
with the optical spectra. A trough in the high power/low
temperature spectrum (Figure 5B) at g′ ≈ 3.1 (2170 G) is due
to rapid passage of the slow-relaxing axial species at the lower
temperature and higher power compared to the spectrum in
Figure 5A.
The EPR spectrum of ZnCo-NDM-1 (Figure 7A and inset)
is complex and appears to contain at least three species. The
major contribution is from a rhombic species characterized by a
59Co hyperﬁne pattern centered at g′ ≈ 6.65 (1010 G), of
which only the higher ﬁeld lines are well-resolved due to
correlated strains in g and A, and broad resonances at ∼ 2800
and ∼ 4000 G. Simulations showed that this signal could not be
modeled assuming an axial g tensor and, therefore, that no
unique solution exists in terms of spin Hamiltonian parameters.
This species was readily simulated assuming a nonunique
Table 2. EXAFS Fitting Results for Metal-Substituted NDM-1a
species model M−N/O M−S M−M ﬁt
ZnZn 4 N/O (2 His) + 0.5 S 1.98 (4.5) 2.25 (4.5) 3.38 (7.6) b
CoCo 4 N/O (2 His) + 0.5 S 2.06 (5.3) 2.29 (5.1) 3.51 (6.9) S1-4
ZnCo (Zn) 4 N/O (3 His) 2.01 (6.5) 3.45 (11) S2-4
(Co) 4 N/O (1 His) + 1 S 2.03 (4.7) 2.32 (5.1) 3.45 (15) S3-5
CoCd (Co) 4 N/O (3 His) 2.01 (3.4) 3.56 (13) S1-3
aDistances (Å) and disorder parameters (in parentheses, σ2 (10−3 Å2)). Fits correspond to those shown in Figure 4; for details, see Supporting
Information. bFit S1-4 from ref 19.
Figure 5. Perpendicular mode RFQ-EPR spectra of the reaction of
CoCo-NDM-1 with chromacef. Spectra A and B are from resting
CoCo-NDM-1. Spectra C and D are from CoCo-NDM-1 after
reaction with chromacef for 10 ms at 3 °C. Spectra E and F are from
CoCo-NDM-1 after incubation with chromacef for 2 min (at which
time all of the added chromacef has been hydrolyzed). Spectra A, C,
and E were recorded at 10 K and 1 mW, and spectra B, D, and F were
recorded at 5 K, 63 mW. Spectral intensities were adjusted for (i) 1/T,
(ii) √(microwave power), and (iii) dilution during rapid-freeze
quenching. In addition, spectra A, C, and E are shown multiplied by a
factor of 2 relative to B, D, and E.
Figure 6. Parallel mode RFQ-EPR spectra of the reaction of CoCo-
NDM-1 with chromacef. Spectrum A is from resting CoCo-NDM-1.
Spectrum B is from CoCo-NDM-1 after reaction with chromacef for
10 ms at 3 °C. Spectrum C is from CoCo-NDM-1 after incubation
with chromacef for 2 min. All spectra were recorded at 5 K and 63 mW
and are shown with the correct relative intensities.
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rhombic g tensor, and further, it could be simulated assuming
either MS = ±
1/2 (e. g., with gx,y,z = 2.45, 2.70, 2.25; E/D = 0.32;
A(59Co) = 9.0 × 10−3 cm−1) or MS = ±
3/2 (e. g., with gx,y,z =
2.38, 2.60, 2.67; E/D = 0.32; Ay(
59Co) = 9.0 × 10−3 cm−1). The
inability to distinguish MS = ±
1/2 and MS = ±
3/2 prevents an
assignment of coordination number, though the high value of
E/D and the relatively slow relaxation of the signal suggests that
5-fold coordination is more likely than 4-fold, and both are
much more likely than 6-fold. There is a broad axial feature
underlying the rhombic signal, which is likely due to a small
amount of unbound Co(II) or to a subpopulation of CoCo-
NDM-1 in the nominally ZnCo-NDM-1 sample.
At lower temperature (Figure 7B) there is evidence, in the
form of an additional peak at g′ = 6.65 (1010 G), for a third
signal consistent with a distorted tetrahedral species. While this
signal is small and in this case represents a minor contributor, it
should be appreciated that the g′x and g′y values may be very
low (approaching zero for true octahedral coordination), and
that the g′x and g′y resonances may therefore be at very high
ﬁeld, making quantitation diﬃcult. The peak intensity of an
EPR signal is inversely related to the square of the spectral ﬁeld
envelope width and the peak intensity of an S = 3/2, MS = ±
3/2
EPR signal due to a nominally tetrahedrally coordinated Co(II)
ion would be expected to be small compared to also-present
MS = ±
1/2 signals, even if it accounted for a considerable
fraction of the spins. The present signal may arise from a small
subpopulation of CoZn-NDM-1 (with Co(II) in the Zn1 site)
or, alternatively, a subpopulation of four-coordinate Co(II) in
the Zn2 site. Another resonance is visible in the spectrum of
ZnCo-NDM-1 at 5 K, a feature that peaks at about g′ = 9.6
(700 G). The line shape of this resonance and the fact that the
EPR absorption ends abruptly at g′ = 10.0 suggest that it is due
to transitions in either or both of the MS = ±
1/2 and ±
5/2
doublets of S = 5/2 Fe(III) with high strains in E and that it is
related to the line at g′ = 4.3.61
The EPR spectrum of CoCd-NDM-1 (Figure 8A) exhibited
an axial signal with a peak at g′ = 5.25 (1280 G) and a resolved
gz resonance at about 2400 G. Simulations returned the
parameters MS = ±
1/2, g⊥ = 2.32, g∥ = 2.40, and E/D = 0.09,
which are most consistent with 5- or 6-fold coordination.
Although the assignment to 5-fold coordination is supported by
the resistance of the signal to rapid passage eﬀects at 5 K
(Figure 8B), the relatively narrow g⊥ feature argues against the
two coordinated water molecules that would be required. The
reduced g-anisotropy relative to the CoCo enzyme and clearly
axial symmetry of the CoCd EPR are consistent with the more
centrosymmetric environment of the pseudotetrahedral Zn1
site.62,63 The very diﬀerent respective values for E/D strongly
diﬀerentiate the predominant Co(II) species in ZnCo-NDM-1
and in CoCd-NDM-1 and indicate that the axial electronic
symmetry and, by inference, the ligand ﬁeld symmetry are
much higher in the Zn1 site than in the Zn2 site. This perhaps is
to be expected given the lone cysteine residue in the Zn2 site
and the intense charge-transfer transition in the optical
spectrum of Co(II) in the Zn2 site (Figure 2).
Simulations and comparison of the spectra of CoCd-NDM-1
at 5 and 10 K (Figure 8A, B) indicate an underlying broad signal at
10 K that contributes a broad shoulder to low ﬁeld of the main
peak and absorption at 2000−4000 G that obscures the gz feature
of the axial species that is well-resolved at 5 K. This broad feature
is likely due to unbound Co(II), which at 5 K and 63 mW is
broadened beyond detection. A small additional EPR signal was
observed at 5 K, apparent as a step on the low-ﬁeld side of the
main peak at g′ ≈ 6.35 (1035 G) and is tentatively assigned to a
minor contribution from a second distorted tetrahedral species.
Diode-Array Optical Studies of ZnZn-, CoCo-, ZnCo-,
and CoCd-NDM-1. Previously, we used diode-array optical
Figure 7. Perpendicular mode RFQ-EPR spectra of the reaction of
ZnCo-NDM-1 with chromacef. Spectra A and B are from resting
ZnCo-NDM-1. Spectra C and D are from ZnCo-NDM-1 after reaction
with chromacef for 10 ms at 3 °C. Spectra E and F are from ZnCo-
NDM-1 after incubation with chromacef for 2 min. Spectra A, C, and
E were recorded at 10 K and 1 mW, and spectra B, D, and F were
recorded at 5 K, 63 mW. Spectral intensities were adjusted for (i) 1/T,
(ii) √(microwave power), and (iii) dilution during rapid-freezing. In
addition, further multiplication factors were applied to spectra B
(×0.5), D (×0.5), E (×3), and F (×0.5). The inset shows expanded
views of A (“Resting”) and C (“RFQ 10 ms”) that highlight the 59Co
hyperﬁne splitting.
Figure 8. Perpendicular RFQ-EPR spectra of the reaction of CoCd-
NDM-1 with chromacef. Spectra A and B are from resting CoCd-
NDM-1. Spectra C and D are from CoCd NDM-1 after reaction with
chromacef for 10 ms at 3 °C. Spectra E and F are from CoCd NDM-1
after incubation with chromacef for 2 min. Spectra A, C, and E were
recorded at 10 K and 1 mW, and spectra B, D, and F were recorded at
5 K, 63 mW. Spectral intensities were adjusted for (i) 1/T, (ii)
√(microwave power), and (iii) dilution during rapid-freeze
quenching. In addition, further multiplication factors were applied to
spectra B (×0.17), C (×4), E (×4), and F (×0.5).
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studies at 9 °C to probe the pre-steady-state reaction of NDM-
1 with chromacef, and we utilized kinetic simulations to oﬀer a
minimal kinetic scheme for the enzyme.19 These studies
revealed that the hydrolysis of chromacef by ZnZn-NDM-1
proceeds through an anionic nitrogen intermediate, and the
decay of this intermediate is rate-limiting for NDM-1 when
chromacef or nitroceﬁn are used as substrate. Here, the reaction
of 25 μM ZnZn-NDM-1 with 22.5 μM chromacef was monitored
using an Applied Photophysics diode array spectrophotometer,
and progress curves corresponding to substrate decay (374 nm),
intermediate formation/decay (575 nm), and product formation
(442 nm) were generated (Figure 9A). Under these conditions, a
large amount of the reaction intermediate is formed over the ﬁrst
10 ms of the reaction, and the rate of intermediate decay (4.8 s−1)
is identical to the rate of product formation (4.9 s−1) (Table 3).
The rate of substrate decay (505 s−1) is also very similar to the rate
of intermediate formation (582 s−1).
Reaction of the metal-substituted variants of NDM-1 with
chromacef was examined in the same way. The rates of
substrate decay, intermediate formation/decay, and product
formation, obtained from single or double exponential ﬁts, are
shown in Table 3. The corresponding progress curves are
shown in Supplementary Figure S6. In all cases, a signiﬁcant
amount of the intermediate was formed, and its rate of
formation mirrored the rate of substrate decay. Interestingly,
the rate of intermediate formation is reduced almost 2-fold
when Zn(II) is replaced with Co(II) in the Zn2 site, while the
rate of product formation is unaﬀected. The rate of
intermediate formation is reduced further, by another factor
of 2, when both Zn(II) ions are replaced with Co(II), while
conversion to product doubles for the CoCo enzyme. Similarly,
the CoCd enzyme forms the intermediate ca. 2-fold more
slowly than its CoCo analogue and nearly 10-fold more slowly
than the ZnZn enzyme, while it converts the intermediate to
product 3-fold more quickly. In total, the data oﬀer a clear
indication that the acidity of the metal ion in the Zn2 site is
critical to stabilization of the anionic intermediate and further
demonstrate a role for each metal ion in both intermediate
formation and its conversion to product. Most importantly, the
data show that all three metal-substituted forms use the same
minimal mechanism as ZnZn-NDM-1.
Microscopic rate constants were determined by ﬁtting the
progress curves to the mechanism in Scheme 1, using Kinteksim.
The mechanism in Scheme 1 diﬀers from that used in our
preceding study, in that it lacks the formation of a product-
complex, as indicated by the RFQ-EPR studies described below.
The resulting simulated traces match the experimental data very
well (Figure 9A and Supplementary Figure S6). Results of the ﬁts
are summarized in Table 3. The microscopic rates for substrate
decay, intermediate formation/decay, and product formation
from Table 3 were used to calculate theoretical kcat and Km values
according to eq 1, and these values are included, for comparison
to the steady-state values, in Table 1. The calculated values diﬀer
substantially (20- to 50-fold) for Km, less so (2- to 3-fold) for kcat.
This disparity arises from inclusion of the substrate on/oﬀ rates
(k1/k−1) in Km. Without an experimental measure, the on rate
(k1) was held ﬁxed at the diﬀusion limit, while the oﬀ rate (k−1)
was treated as a parameter.
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Included in Table 3 is a reanalysis of our earlier results for
the reaction of ZnZn-NDM-1 with chromacef, obtained at
Figure 9. Progress curves for reaction of 22.5 μM chromacef with 25 μM ZnZn-NDM-1 at 9 °C, under single turnover conditions. (A) Reaction
followed by diode array spectrophotometry. (B) Reaction followed by tryptophan ﬂuorescence emission. In both, the symbols are experimental data
(only 1/10th of the data points are shown, for clarity), and the solid lines are Kinteksim simulations, based on the mechanism in Scheme 1.
Table 3. Results of Single Turnover Experiments with
Chromacef at 9 °C
species measurement k2 (s
−1) k3 (s
−1)a
ZnZn ﬂuorescence 676 ± 11 5.1
A374 505 ± 19
A442 4.8
A575 582 ± 7 4.9
sim (9 °C)b 670 ± 70 4.8
sim (15 °C)b 395 ± 7 8.7
sim (22 °C)c 700 ± 100 12.0
ZnCo ﬂuorescence 225 ± 6 3.7
A374 290 ± 8
A442 4.5
A575 341 ± 4 4.5
simb 550 ± 50 4.7
CoCo ﬂuorescence 135 ± 2 10.4
A374 156 ± 5
A442 10.1
A575 183 ± 3 10.1
simb 500 ± 50 10.0
CoCd ﬂuorescence 65 ± 1 15.7
A374 54 ± 1
A442 15.5
A575 77 ± 1 14.8
simb 150 ± 70 16.0
aUncertainty in k3 is ca. ± 0.1.
bFrom Kinteksim simulations, using the
mechanism in Scheme 1. The value of k1 was held ﬁxed at 10
9 s−1.
Values of k−1 ranged from 4000 to 8000 (±1000).
cFrom a reanalysis
of the data reported in ref 19, using the mechanism in Scheme 1.
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22 °C (rather than the 9 °C used broadly here), along with an
additional measurement at 15 °C. Perhaps not surprisingly, the
only microscopic rate constant aﬀected by temperature is the
rate-limiting step, k3, which increases 2.5-fold from 9° to 22 °C.
This suggests a large energy of activation associated with
product release, and an Arrhenius plot involving k3
(Supplementary Figure S7) sets the energy of activation at
12 ± 2 kcal mol−1, in good agreement with values obtained
through QM/MM calculations on CcrA (B1)64 and L1 (B3).65
The associated Eyring plot (Supplementary Figure S7) shows a
large entropic contribution to the energetics of product
generation (ΔH⧧ = 5.2 kcal mol−1; ΔS⧧ = 8.4 kcal mol−1 K−1.
Stopped-Flow Fluorescence of ZnZn-, ZnCo-, CoCo-,
and CoCd-NDM-1. The crystal structure of resting ZnZn-
NDM-1 shows that Trp93 is ca. 8.0 and 5.7 Å from the metal
ions in the Zn1 and Zn2 binding sites, respectively.
66 These
distances increase to 8.1−8.4 Å (Zn1) and 6.0−6.2 Å (Zn2) in
the structure of hydrolyzed meropenem bound to ZnZn-NDM-1.
Similar distance increases with bound hydrolyzed ampicillin,
benzylpenicillin, methicillin, oxacillin, and captopril have been
observed,67,68 suggesting the ﬂuorescence of Trp93 can be used to
monitor the reaction with substrate, as was demonstrated
previously with MβL L1 and nitroceﬁn.69,70
Stopped-ﬂow ﬂuorescence studies at 9 °C using 25 μM
ZnZn-NDM-1 and 22.5 μM chromacef revealed a biphasic
curve in which the ﬂuorescence dropped precipitously during
the ﬁrst 10 ms of the reaction and then increased exponentially
over the next 500 ms (Figure 9B). These data are similar to
those reported for L1 with nitroceﬁn, and ﬁtting these data to a
double-exponential yielded rate constants of 676 s−1 for the
ﬂuorescence decay and 5.1 s−1 for the ﬂuorescence return
(Table 3). These values are very similar to those obtained from
the diode array studies. Control experiments using apo-NDM-1
showed no changes in ﬂuorescence, demonstrating the
observed signal changes were due to substrate binding/
catalysis. CoCo-, ZnCo-, and CoCd-NDM-1 each exhibited
ﬂuorescence progress curves similar to that of ZnZn-NDM-1
(Supplementary Figure S6). The rates of ﬂuorescence decay/
return (s−1) were 134/10.3, 225/4.6, and 65/15.7 for CoCo-,
ZnCo-, and CoCd-NDM-1, respectively.
Since the rates of ﬂuorescence growth were very similar to
the rates of product formation in the single-turnover diode
array studies, we used the ﬂuorescence quenching rates as a
function of chromacef concentration to determine Ks values for
substrate binding to the various isoforms.71 A representative
plot is shown in Figure 10. The Ks values, determined by ﬁtting
these data to eq 2, for ZnZn-, ZnCo-, CoCo-, and CoCd-NDM-1
were 14.6, 18.1, 12.3, and 11.2 μM, respectively. These values
clearly suggest that metal substitution does not signiﬁcantly alter
substrate aﬃnity.
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RFQ-EPR of CoCo-, ZnCo-, and CoCd-NDM-1. To gauge
the intimate changes taking place at each metal site, we
performed rapid-freeze-quench EPR experiments. For each of
the CoCo-, ZnCo-, and CoCd-NDM-1 species, quite dramatic
eﬀects were observed in the EPR spectra upon reaction with
chromacef. These eﬀects were distinct for each of the species,
providing insight into the role of each metal ion and the metal
center as a whole.
In CoCo-NDM-1, about two-thirds of the g′ = 5.2, S = 3/2,
MS = ±
1/2 signal is lost upon reaction with chromacef for
10 ms at 3 °C (Figure 5). The zero-ﬁeld signal is lost completely,
and a new integer-spin signal with g′ = 9.2 (725 G) is observed
with about three times the intensity of the g′ = 8 signal from the
resting enzyme. In parallel mode, where the g′ values are
consistently larger than those observed when B0⊥B1, the shift
upon reaction with chromacef is from g′ = 8.6 to g′ = 9.9
(Figure 6). This may indicate a shift from S′ = 2, which is an
excited state of the spin ladder and indicates antiferromagnetic
coupling in the absence of a ground state accompanying S′ = 3
signal, to an S′ = 3 ground state of a ferromagnetic spin ladder
(S′ = 3, 2, 1, 0). Such signals have been found for phosphonate-
bridged Co(II) ions in the active site of aminopeptidase from V.
proteolyticus.72 By analogy, then, we tentatively assign the signal
to bidentate binding of chromacef across the two Co(II) ions in
CoCo-NDM-1, suggesting a rationale for the dinuclear metal
center in NDM-1. Upon completion of the reaction, only a very
weak residual integer-spin signal was observed, and only with
B0∥B1 (Figure 6C). Although the integer-spin signal is smaller,
measurements with B0⊥B1 (Figure 5E, F) show a S = 3/2, MS =
± 1/2 signal that is essentially indistinguishable from the resting
signal, indicating that CoCo-NDM-1 does not form a strong
product complex.
The most striking change in the EPR spectrum of ZnCo-
NDM-1 upon reaction with chromacef (Figure 7) is a change
in the 59Co hyperﬁne splitting, from a typical value of 9 ×
10−3 cm−1 in the resting enzyme to 5.5 × 10−3 cm−1 (Figure 7C
and inset). This indicates signiﬁcant electron delocalization
away from the Co(II), which in turn is indicative of direct and
likely multidentate binding of chromacef to Co(II) in the Zn2
site of ZnCo-NDM-1. The hyperﬁne-exhibiting species could
be simulated and assigned to an MS = ±
1/2 ground state with
moderate rhombic distortion of the axial zero-ﬁeld splitting,
indicating 5-fold geometry (g⊥ = 2.45, g∥ = 2.20, Ay(
59Co) =
5.5 × 10−3 cm−1, and E/D = 0.17). Upon allowing the reaction
to go to completion, a new relatively sharp signal devoid of
resolved hyperﬁne structure was observed at g′ = 5.45 (1230 G)
(Figure 7E). This signal could be simulated assuming MS = ±
1/2,
g⊥ = 2.32, g∥ = 2.50, and E/D = 0.12, but most of the EPR
absorption is featureless, and the signal displayed unusual and
anisotropic dependence on temperature and microwave power
(Figure 7F) that suggests that more than one species may be
involved. The resemblance of the rapid-passage feature at 2000 G
in spectrum 7F to those in 6B and 6F suggest either some
scrambling of the metal ions upon extended reaction, to form a
Figure 10. Plot of observed rate constant for ﬂuorescence emission
quenching (kobs, s
−1) versus chromacef concentration for ZnZn-,
ZnCo-, CoCo-, and CoCd-NDM-1. Ks was determined by ﬁtting the
data to eq 2 for each analogue.
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subpopulation of CoCo-NDM-1, or some unbound Co(II) in
both the ZnCo- and CoCo-NDM-1 samples.
The EPR spectrum of CoCd-NDM-1 upon reaction with
chromacef for 10 ms (Figure 8) showed a quite dramatic shift
in the position of the main resonance peak from g′ = 5.25
(1280 G) to 6.0 (1110 G) (Figure 8C). The peak at g′ = 6.0
sharpened and increased in intensity by a factor of 4, after
applying correction factors, upon lowering the temperature
from 10 to 5 K and increasing the power from 1 to 63 mW,
indicating very fast relaxation. It is tempting to assign this signal
to MS = ±
3/2, but the broad absorption extending from 2000
to 4000 G exhibited a similar intensity dependence and
appeared to begin to resolve into two distinct resonances at the
lower temperature, a derivative shape around 1900 G and a gz
absorption line at 3000 G. If all of these resonances are indeed
associated, as the relaxation behavior seems to indicate, then
the assignment is to a ﬁve-coordinate Co(II) with a distorted
and highly rigid coordination sphere, providing unusually
strong coupling to the lattice. The lack of resolved hyperﬁne
coupling on the g′ = 6 line (strictly speaking, the gy resonance
of a S = 3/2, MS = ±
1/2 system) means that the coupling is
primarily in one of the other orientations and is strain-
broadened beyond detection. However, this clearly diﬀer-
entiates the Co(II) in the Zn1 site of CoCd-NDM-1 from that
in the Zn2 site of ZnCo-NDM-1. Upon extended reaction with
chromacef, the EPR signal reverts essentially to the resting
state, although the underlying broad absorption in spectrum 8A
is no longer present in spectrum 8E, indicating that the broad
absorption in the resting state is due to a species that is
returned to the native state through turnover.
■ DISCUSSION
The NDM-1 plasmid that harbors the gene for metallo-β-
lactamase NDM-1, along with other resistance genes, has
emerged as one of the most important players in recent clinical
reports of antibiotic resistance. A great deal of enzymological
data has been reported on NDM-1.19,24,66,67,73−83 To date,
structural studies on this enzyme have been limited to X-ray
crystallography66,67 and EXAFS spectroscopy.19 Successful
preparation of spectroscopically active, metal-substituted
forms of NDM-1 has allowed us to perform more detailed
structural studies, including the use of rapid-freeze-quench
methods to examine the catalytic mechanism at the atomic
level.
Several diﬀerent strategies have been developed to prepare
metal-substituted forms of the metallo-β-lactamases.18,21−23,45,84
Previous reports have shown oxidation of the active site cysteine in
other B1 MβLs as a direct result of cobalt substitution, most
notably for CcrA45 and BcII.22 We ﬁnd that Cys208 in NDM-1 is
much more susceptible to Co-mediated oxidation, obtaining only
Co(III)-containing and substoichiometrically loaded protein, on
direct addition of Co(II) to the apoprotein. The prophylactic
addition of a reducing agent (TCEP), prior to addition of Co(II),
prevents Co(II)-mediated oxidation, allowing relatively easy
preparation of a di-Co(II) form of NDM-1, as well as the
heterodimetallic forms reported here. Methods have been
described to prepare heterodimetallic forms of other dinuclear
zinc enzymes,85 including the MβLs BcII20 and L1.21 However, to
our knowledge, this is the ﬁrst report of metal-substituted MβLs
that were site-speciﬁcally loaded with a paramagnetic Co(II) ion in
either the Zn1 or the Zn2 position, while incorporating a
diamagnetic metal ion in the other.
The optical, NMR, EPR, and EXAFS studies presented here
clearly support the descriptions above, with an intact dinuclear
center in each metal-substituted form, in which the metal ions
are sequentially loaded. In combining the results of multiple
techniques, it is important to be mindful of the relative
sensitivities and limitations of each technique. For example, the
optical and NMR studies, as well as the kinetic studies
discussed below, were carried out near room temperature, in
ﬂuid solution. The optical spectra, with bands spanning
Scheme 2
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hundreds of cm−1, will report only gross structural hetero-
geneity, with subtleties absorbed into the apparent extinction
coeﬃcients. NMR is much more sensitive, but only static
structural heterogeneity will be easily detected, with dynamic
processes manifest as additional broadening of an already broad
resonance. In contrast, the EXAFS and the EPR are performed
in frozen solution, at or near liquid helium temperatures.
EXAFS, as a bulk sampling technique (measuring a weighted
average), can tolerate 5−10% of an impurity before it
signiﬁcantly aﬀects the best-ﬁt model, depending on the
system. Meanwhile, the EPR is sensitive to the same structural
heterogeneity that may appear as line broadening in the NMR,
but without dynamics, these are represented as alternate
conformations and subpopulations, each with its own EPR
response. As the EPR signals of high-spin Co(II) centers span
several thousand Gauss at X-band, small changes in electronic
structure are readily observed, while the EPR response of
Co(II) in a given geometry and the electronic structure
associated with it are not easily comparable to the response of
Co(II) in another geometry, as described above. Consequently,
although the EPR is most sensitive to structural heterogeneity,
quantiﬁcation is diﬃcult. Given these limitations, we can
conservatively state that all of the heterobimetallic enzymes
studied here were > 90% in the resting form shown in the
upper left of Scheme 2, with the metals distributed as indicated.
The EXAFS-derived metal−metal separations (Table 2)
track with the covalent radii of the metal ions (3.38 Å (Zn−Zn)
to 3.45 Å (Zn−Co) to 3.51 Å (Co−Co) to 3.56 Å (Co−Cd)),
suggesting there is only minimal modulation of the metal−
oxygen−metal angles, which we would expect to translate into
only minor diﬀerences in reaction rates, as is seen. In steady-
state kinetic studies, all three forms (CoCo-, ZnCo-, and CoCd-
NDM-1) were seen to exhibit Km and kcat values within a factor
of 2−3 of those for ZnZn-NDM-1. A similar observation can be
made with regard to the single turnover experiments. Stopped-
ﬂow ﬂuorescence using chromacef as substrate indicated nearly
identical substrate aﬃnities and product release rates within a
factor of 3−4 across the series of enzymes, suggesting the metal
substitutions did not cause gross changes in the structure of the
active site or its ability to function as an MβL.
Stopped-ﬂow optical studies demonstrated that a ring-
opened, anionic intermediate was observed with all four
metal-substituted forms of NDM-1. While the ZnZn, ZnCo,
and CoCo analogues formed the intermediate in near
stoichiometric amounts, the CoCd enzyme builds up to only
ca. 50% of the total enzyme concentration, the combined eﬀect
of a 10-fold decrease in the rate of intermediate formation (k2
in Table 3) and a 3-fold increase in the rate of product release
(k3), relative to ZnZn-NDM-1. Overall, the rates of
intermediate formation and decay are comparable, suggesting
that the identity of the metal ions does not greatly aﬀect the
overall energetics of the reaction. The rate-limiting step for all
four forms of the enzyme is clearly protonation of the
intermediate, as proposed earlier for other MβLs.21,86−88 The
product release rates nicely track the Lewis acidity of the metal
in the Zn2 site (Zn(II) > Co(II) > Cd(II)) but are also aﬀected
by the identity of the metal in the Zn1 site. Both forms with
Zn(II) in the Zn1 site (ZnZn and ZnCo) show k3 ≈ 5 s−1 at
9 °C, while the two forms with Co(II) in the Zn1 site (CoCo
and CoCd) are 2−3 times faster at 10 and 16 s−1, respectively.
Further freeze-quench spectroscopic studies will be required to
completely disentangle the individual contributions.
Rapid-freeze-quench EPR studies showed signiﬁcant changes
in the Co(II) ion electronic structure, whether residing in the
Zn1 site or the Zn2 site, as well as in the dinuclear Co(II)
center, on a catalytically relevant time scale. These observations
are summarized in the proposed mechanism in Scheme 2.
Co(II) in the Zn1 site (as in CoCd-NDM-1) undergoes a
marked change in electronic structure upon reaction with
substrate, indicative of a decrease in coordination symmetry,
and exhibits very fast electronic relaxation, suggestive of a very
rigid coordination sphere. On the basis of these observations,
we favor a ﬁve-coordinate Co(II). While Scheme 2 depicts
simultaneous coordination of both O atoms from the newly
formed carboxylate of the ring-opened intermediate (one from
the μ-OH ligand, one from the substrate carbonyl), we cannot
rule out the presence of an incoming water molecule, possibly
reforming the bridge, and monodentate coordination of the
newly formed carboxylate. Either interpretation suggests a clear
role for the Zn1 ion in nucleophile activation and/or delivery.
In contrast, for Co(II) in the Zn2 site, a dramatic reduction in
the 59Co hyperﬁne splitting provides clear evidence for binding
of a moiety capable of absorbing delocalized spin density from
the Zn2-site metal ion, on the same time scale as the events
described above for the Zn1-site metal ion. Only Cd(II)
substitution had a signiﬁcant eﬀect on the rate of intermediate
formation, suggesting a major role for the Zn2 ion in
electrophilic activation of the substrate and stabilization of
the anionic intermediate, providing further rationale for the
coordinated cysteine in the Zn2 site.
42 We note here that the
cysteinate is trans to the position the anionic nitrogen would
occupy.
The simultaneous binding of the intermediate to both metal
ions and the loss of the μ-OH bridge are supported by the
RFQ-EPR of CoCo-NDM-1. The resting state spectrum shows
that a small proportion of the dinuclear center exists in a very
weakly, and probably antiferromagnetically, exchange coupled
state. In the 10 ms RFQ sample, on the other hand, more than
60% of the centers exhibit exchange coupling, also weak, but
probably ferromagnetic and not due to a commonly bound
single atom. After extended reaction, the Zn1 ion returns to its
resting coordination, whereas the electron-density-donating
Zn2 ion remains bound to the product at the high
concentrations used for RFQ-EPR. These data are consistent
with the very small integer spin signal seen upon extended
reaction of CoCo-NDM-1 with chromacef.
■ SUMMARY
In summary, the reaction mechanism of NDM-1 was investigated
by creating heterodimetallic forms of NDM-1 and using the
chromogenic substrate chromacef. The coordination environ-
ment of each metal site was studied by speciﬁcally incorporating
a paramagnetic Co(II) ion independently into either the Zn1 or
the Zn2 site. Our kinetic studies demonstrate that the rate-
limiting step in the hydrolysis reaction is the decay of a common
reaction intermediate, and that the rate of product formation is
dependent on the acidity of the metal ion in the Zn2 site. The
spectroscopic studies show clear roles for both metals at all stages
of the reaction.
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Seven ﬁgures and four tables showing 1H NMR of CoCo-,
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temperature-dependent kinetics (Figure S7). This material is
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